First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients

NCT02612051 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: GSK3008348 Nebuliser solution
DRUG: Placebo Nebuliser solution
RADIATION: GSK26346763: ([18F]-FBA-A20FMDV2) IV infusion

Sponsor

GlaxoSmithKline